Enteric Neurons In Gut Brain Axis is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The enteric nervous system (ENS), often called the "second brain," is a complex network of neurons embedded in the lining of the gastrointestinal tract. It controls gut motility, secretion, blood flow, and immune function independently of the central nervous system. The ENS communicates bidirectionally with the brain via the vagus nerve and spinal cord, forming the gut-brain axis, which has emerged as a critical pathway in neurodegenerative diseases, particularly Parkinson's disease. [@braak2003]
The ENS consists of two major ganglionated plexus:
Myenteric Plexus (Auerbach's Plexus)
Located between the longitudinal and circular muscle layers
Primarily controls gastrointestinal motility
Contains sensory neurons, motor neurons, and interneurons
Coordinates peristalsis and segmentation
Submucosal Plexus (Meissner's Plexus)
Located in the submucosa
Regulates secretion, blood flow, and mucosal immune function
Contains sensory neurons that detect luminal contents
Interfaces with the epithelial barrier
Enteric Neuron Types
Sensory Neurons
Intrinsic primary afferent neurons (IPANs): Detect stretch, chemical changes, and nutrient content
Extrinsic afferents: Transmit signals via vagal and spinal pathways to the CNS
Motor Neurons
Excitatory motor neurons: Release acetylcholine to stimulate contraction
Inhibitory motor neurons: Release nitric oxide and VIP to promote relaxation
Interneurons
Ascending interneurons: Propagate signals orally
Descending interneurons: Propagate signals anally
Role in Parkinson's Disease
The gut-brain axis has become a focal point in Parkinson's disease research, with evidence suggesting that alpha-synuclein pathology may originate in the enteric nervous system and propagate to the brain via the vagus nerve.
Alpha-Synuclein Propagation Hypothesis
Initiation in ENS: Misfolded alpha-synuclein may first aggregate in enteric neurons
Retrograde transport: Pathological proteins travel via the vagus nerve to the dorsal motor nucleus of the vagus
Brainstem progression: Pathology spreads to the locus coeruleus and substantia nigra pars compacta
Cortical spread: Eventually reaches cortical regions in advanced disease
Clinical Evidence
Constipation: One of the earliest prodromal symptoms of PD, often preceding motor symptoms by decades [1]
Lewy bodies: Alpha-synuclein inclusions found in enteric neurons of PD patients [2]
Gut permeability: Increased intestinal permeability observed in PD patients [3]
Gastrointestinal Dysfunction in PD
Gut Microbiome Interactions
The ENS serves as an interface between the gut microbiome and the nervous system:
Microbial metabolites: Short-chain fatty acids (SCFAs) modulate enteric neuron function
Immune activation: Bacterial components can trigger neuroinflammation via the ENS
Neurotransmitter production: Gut bacteria produce precursors for serotonin and dopamine
Therapeutic Implications
Probiotic Interventions
Certain probiotic strains may reduce gastrointestinal symptoms in PD
Modulation of gut microbiota could potentially slow alpha-synuclein aggregation
Targeting the Vagus Nerve
Vagotomy (surgical removal of the vagus nerve) associated with reduced PD risk in some studies [4]
Non-invasive vagus nerve stimulation being explored for PD treatment
The study of Enteric Neurons In Gut Brain Axis has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.